Glenmark Life Sciences, a subsidiary of Glenmark Pharmaceuticals Ltd, is one of the leading developers and manufacturers of select high-value Active Pharmaceutical Ingredients. The company further operates in Contract Development and manufacturing operations to offer services to specialty Pharmaceutical companies.
TTM PE : 15.87 (High PE) Sector PE : 48.06 Beta : 0.55
📚 INSIGHTS MC Insights PRO Stock with consistent financial performance, quality management, and strong technical momentum indicating good investor enthusiasm. Currently valued at Good to expensive valuation
3.00% away from 52 week high Underperformer - Glenmark Life Sciences up by 3.14% v/s NIFTY 50 up by 8.32% in last 1 month
📈 FINANCIALS Piotroski Score of 6/9 indicates Average Financials
Disclaimer: This analysis is for educational purposes only, and I'm not a SEBI registered analyst. If you found this analysis helpful, I encourage you to like and share it. Your observations and comments are also welcomed below. Your support, likes, follows, and comments motivate me to consistently share valuable insights with you.
🔍 More Analysis & Trade Setups 🔍 For more technical analysis and trade setups, make sure to follow me on TradingView: tradingview.com/u/Munish_Jain/